Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
10.07.24
/
50%
€67.50
Target price
10.07.25
€94.20
Performance (%)
23.70%
End price
11.07.25
€83.50
Summary
This prediction ended on 11.07.25 with a price of €83.50. The prediction had a final performance of 23.70%. The_Goldman_Sachs_Gr has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Insmed Inc. | 10.000% | 10.000% | 103.077% |
iShares Core DAX® | 2.850% | 3.312% | 26.690% |
iShares Nasdaq 100 | 1.612% | 5.652% | 17.265% |
iShares Nikkei 225® | 6.401% | 11.958% | 14.877% |
iShares S&P 500 | 1.346% | 4.130% | 10.995% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $74.00 to $102.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten